Workflow
Buy, Sell or Hold J&J Stock? Key Tips Ahead of Q1 Earnings
JNJJ&J(JNJ) ZACKS·2025-04-11 16:35

Johnson & Johnson (JNJ) will begin the earnings season for the drug & biotech sector when it reports its first-quarter 2025 results on April 15. The Zacks Consensus Estimate for first-quarter sales and earnings is pegged at 21.66billionand21.66 billion and 2.57 per share, respectively. The Zacks Consensus Estimate for J&J’s earnings has declined from 10.58pershareto10.58 per share to 10.57 per share for 2025, while that for 2026 has declined from 11.07pershareto11.07 per share to 11.02 per share over the past 60 days.Find the latest EPS estimate ...